 |
|
|
|
|
Post-Surgery Radiation Boosts Prostate Cancer Results
|
| | | | Related Healthscout Videos | |
|
Page: << Prev | 1 | 2 | 3 | 4 So, while this tissue sampling of 44 men found testosterone therapy to have no cancer-promoting effects, those results might not be borne out in larger epidemiological studies, he said. Until such studies are done, Marks said, "My concern is that some physicians may misinterpret these data and start using testosterone willy-nilly. My hope is that it won't be used that way."
A third study in the same issue of JAMA offered some guidance to millions of men bothered by urinary incontinence triggered -- at least in part -- by an enlarged prostate.
The study of more than 700 men found that a combination of two widely used medications, tolterodine (Detrol LA) and tamsulosin (Flomax), worked better in combination at reducing urinary trouble than either drug alone.
Text Continues Below
"In those men who don't respond to a single therapy -- and that's a host of men -- we're able to now, with this combination, provide a real improvement in their quality of life," said lead researcher Dr. Stephen Kaplan, professor of urology at Weill Medical College of Cornell University, in New York City.
More information
Find out more about prostate health at the U.S. Food and Drug Administration (www.fda.gov ).
Page: << Prev | 1 | 2 | 3 | 4
|
Copyright © 2006 ScoutNews, LLC. All rights reserved.
Last updated 11/14/2006
|
|
SOURCES: Nov. 14, 2006, news briefing, American Medical Association, New York City, with Gregory Swanson, M.D., associate professor, radiation oncology, University of Texas Health Science Center, San Antonio; Dr. Stephen Kaplan, M.D., professor, urology, Weill Medical College of Cornell University, New York City; Leonard Marks, M.D., medical director, Urological Sciences Research Foundation, Culver City, Calif., and clinical professor, surgery/urology, UCLA School of Medicine; Nov. 15, 2006, Journal of the American Medical Association
|
.gif)
